Psoriasis vulgaris, a chronic inflammatory disease, associates with oxidative stress, dislipidaemia,
overweight/obesity, low adiponectin levels and a high frequency in cardiovascular
diseases (CVD) [
1
,
2
,
3
,
4
,
5
]. However, there are no reports studying the relation of CVD risk factors with body
mass index (BMI), severity and duration of psoriasis.To read this article in full you will need to make a payment
Purchase one-time access:
Academic & Personal: 24 hour online accessCorporate R&D Professionals: 24 hour online accessOne-time access price info
- For academic or personal research use, select 'Academic and Personal'
- For corporate R&D use, select 'Corporate R&D Professionals'
Subscribe:
Subscribe to Journal of Dermatological ScienceAlready a print subscriber? Claim online access
Already an online subscriber? Sign in
Register: Create an account
Institutional Access: Sign in to ScienceDirect
References
- Dislipidemia and oxidative stress in mild and in severe psoriasis as a risk for cardiovascular disease.Clin Chim Acta. 2001; 303: 33-39
- Evaluation of the atherogenic tendency of lipids and lipoprotein content and their relationships with oxidant-antioxidant system in patients with psoriasis.Clin Chim Acta. 2003; 328: 71-82
- Obesity in psoriasis: the metabolic, clinical and therapeutic implications Report of an interdisciplinary conference and review.Br J Dermatol. 2007; 157: 649-655
- Clear differences in adiponectin level and glutathione redox status revealed in obese and normal-weight patients with psoriasis.Br J Dermatol. 2008; 159: 1364-1367
- Plasma adiponectin and leptin levels in Japanese patients with psoriasis.Br J Dermatol. 2008; 159: 1207-1208
- Severe psoriasis – oral therapy with a new retinoid.Dermatologica. 1978; 157: 238-244
- The clinical spectrum of psoriasis.Clin Dermatol. 2007; 25: 510-518
- Formation of malonaldehyde from phospholipid arachidonate during microsomal lipid peroxidation.Eur J Biochem. 1968; 6: 126-130
- Inflammation as a cardiovascular risk factor.Circulation. 2004; 109 (II2 II10)
- Effects of tumor necrosis factor blockade on cardiovascular risk factors in psoriatic arthritis: a double-blind, placebo-controlled study.Arthritis Rheum. 2007; 56: 831-839
Article info
Publication history
Published online: July 12, 2010
Received:
February 23,
2009
Identification
Copyright
© 2009 Japanese Society for Investigative Dermatology. Published by Elsevier Inc. All rights reserved.